Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

PURPOSE: Several mechanisms have been proposed to explain tamoxifen resistance of estrogen receptor (ER) –positive tumors, but a clinically useful explanation for such resistance has not been described. Because the ER is the treatment target for tamoxifen, a linear association between ER expression...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kim, Chungyeul, Tang, Gong, Pogue-Geile, Katherine L., Costantino, Joseph P., Baehner, Frederick L., Baker, Joffre, Cronin, Maureen T., Watson, Drew, Shak, Steven, Bohn, Olga L., Fumagalli, Debora, Taniyama, Yusuke, Lee, Ahwon, Reilly, Megan L., Vogel, Victor G., McCaskill-Stevens, Worta, Ford, Leslie G., Geyer, Charles E., Wickerham, D. Lawrence, Wolmark, Norman, Paik, Soonmyung
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2011
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208536/
https://ncbi.nlm.nih.gov/pubmed/21947828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.9615
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia